Back
20
Day Range
$320.22
$331.27
52-Week Range
$265.59
$377.54
Volume
948,549
50D / 200D Avg
$354.06
/
$324.91
Prev Close
$326.91
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (625 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 40.1 | 14.0 |
| P/B | 41.4 | 2.4 |
| ROE % | 144.3 | 11.4 |
| Net Margin % | 0.5 | 10.1 |
| Rev Growth 5Y % | 10.7 | 7.0 |
| D/E | 7.1 | 0.5 |
Key Takeaways
Revenue grew 10.70% annually over 5 years — strong growth
ROE of 144.31% indicates high profitability
Debt/Equity of 7.13 — high leverage
Generating 3.21B in free cash flow
P/E of 40.13 — premium valuation
Cash machine — converts 206.36% of earnings into free cash flow
Growth
Revenue Growth (5Y)
10.70%
Revenue (1Y)9.31%
Earnings (1Y)2.99%
FCF Growth (3Y)-3.63%
Quality
Return on Equity
144.31%
ROIC22.32%
Net Margin0.48%
Op. Margin1.14%
Safety
Debt / Equity
7.13
Current Ratio0.90
Interest Coverage8.69
Valuation
P/E Ratio
40.13
P/B Ratio41.36
EV/EBITDA18.84
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 9.31% | Revenue Growth (3Y) | 10.71% |
| Earnings Growth (1Y) | 2.99% | Earnings Growth (3Y) | -5.63% |
| Revenue Growth (5Y) | 10.70% | Earnings Growth (5Y) | 0.23% |
| Profitability | |||
| Revenue (TTM) | 321.33B | Net Income (TTM) | 1.55B |
| ROE | 144.31% | ROA | 2.03% |
| Gross Margin | 3.16% | Operating Margin | 1.14% |
| Net Margin | 0.48% | Free Cash Flow (TTM) | 3.21B |
| ROIC | 22.32% | FCF Growth (3Y) | -3.63% |
| Safety | |||
| Debt / Equity | 7.13 | Current Ratio | 0.90 |
| Interest Coverage | 8.69 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 40.13 | P/B Ratio | 41.36 |
| P/S Ratio | 0.19 | PEG Ratio | 7.05 |
| EV/EBITDA | 18.84 | Dividend Yield | 0.01% |
| Market Cap | 62.37B | Enterprise Value | 68.72B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 321.33B | 293.96B | 262.17B | 238.59B | 213.99B |
| Net Income | 1.55B | 1.51B | 1.75B | 1.70B | 1.54B |
| EPS (Diluted) | 7.96 | 7.53 | 8.53 | 8.04 | 7.39 |
| Gross Profit | 10.14B | 8.70B | 7.76B | 7.60B | 6.27B |
| Operating Income | 3.65B | 3.04B | 2.45B | 2.75B | 2.68B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 76.59B | 67.10B | 62.56B | 56.56B | 57.34B |
| Total Liabilities | 74.84B | 66.31B | 61.89B | 56.49B | 56.75B |
| Shareholders' Equity | 1.51B | 645.94M | 522.00M | -211.56M | 223.35M |
| Total Debt | 10.75B | 6.65B | 6.82B | 7.59B | 8.75B |
| Cash & Equivalents | 4.39B | 3.23B | 2.69B | 3.53B | 2.55B |
| Current Assets | 52.24B | 47.72B | 42.80B | 39.59B | 38.80B |
| Current Liabilities | 57.82B | 54.28B | 48.83B | 43.48B | 41.36B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#441 of 607
Recent Activity
Entered
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026